A repair-associated bronchial epithelial differentiation trajectory through KRT14+ basal and hillock-like cells drives airway inflammation and remodelling in childhood-onset asthma

The airways inside our lungs are lined with a delicate layer of cells, a living barrier that keeps the outside world from invading our internal organs. This lining, known as the epithelium, is not a static wall but a dynamic tissue that constantly repairs itself when damaged by dust, smoke, or viruses. In a healthy person, this repair process is a quiet, efficient routine: damaged cells are replaced by new ones that mature into the specific types needed to keep the airways clear and functioning. However, in asthma, this system goes awry. The airways become chronically inflamed, the lining thickens, and the barrier becomes leaky, allowing irritants to trigger further immune responses. While doctors have long known that asthma involves this faulty repair and a buildup of mucus, the precise cellular machinery driving these changes has remained a mystery. Understanding exactly how the cells behave in asthma is crucial because it could reveal why the disease persists and how to stop the cycle of inflammation and scarring that damages the lungs over time.

A team of researchers has now mapped this cellular landscape in unprecedented detail, creating a comprehensive atlas of the airway walls from twenty-one adults who developed asthma in childhood and twenty-five healthy volunteers. By analyzing hundreds of thousands of individual cells from tiny tissue samples taken from the lungs, they discovered that the airways in people with asthma are stuck in a state of constant, frantic repair. Instead of following the usual path to maturity, a significant portion of the cells in asthmatic lungs are taking a detour through a strange, alternative route. This detour begins with a specific group of stem cells that are primed for repair. These cells, which the researchers identified as being distinct from the normal resting stem cells, start to divide and transform into a transitional state they call "hillock-like" cells. These hillock-like cells are not a standard part of the healthy airway lineup; they appear to be a temporary, intermediate form that the cells adopt when the tissue is under stress.

The study reveals that in people with asthma, this alternative path is far more active than in healthy individuals. The researchers found that the airways of asthmatic patients are filled with a higher number of these repair-associated stem cells and the hillock-like cells they produce. Crucially, the team showed that this behavior is built into the cells themselves. When they took cells from the lungs of these patients and grew them in a dish without any external triggers like viruses or pollutants, the cells still preferred this alternative path. This suggests that the tendency to take this repair detour is an intrinsic feature of the disease, likely programmed by genetics or early-life events, rather than just a reaction to current inflammation.

As these hillock-like cells continue their journey, they face a critical decision point. In a healthy airway, cells usually mature into either mucus-producing goblet cells or ciliated cells that sweep debris out of the lungs. In asthma, however, the presence of a specific immune signal, a protein called IL-13, pushes these hillock-like cells to become a specific, hyperactive type of goblet cell. These cells are distinct from the goblet cells found in healthy people; they are loaded with the machinery to produce massive amounts of mucus. The researchers observed that these cells express high levels of a protein called CEACAM5, which marks them as the source of the thick, sticky mucus that clogs the airways in asthma. This finding connects the dots between the faulty repair mechanism and the hallmark symptom of the disease: excessive mucus production.

The study also uncovered a tragic side effect of this frantic activity. While the airways are churning out new cells at a high rate, the mature ciliated cells that are supposed to keep the airways clean are dying off faster than they can be replaced. The researchers identified a population of dying ciliated cells in the asthmatic airways that are releasing chemical signals to recruit immune cells, effectively sounding an alarm that keeps the inflammation going. This creates a vicious cycle: the dying cells trigger more inflammation, which drives the stem cells to keep trying to repair the damage, leading to more cell death and more inflammation. The immune system, particularly a type of white blood cell called a mast cell, is heavily involved in this loop, sending signals that encourage the epithelial cells to keep dividing and differentiating in this unproductive way.

The researchers linked these cellular findings directly to the severity of the disease in their patients. They found that the more of these repair-associated cells and hyperactive mucus cells a patient had, the worse their lung function and the higher their levels of airway inflammation. This correlation suggests that the alternative repair pathway is not just a side effect but a central driver of the disease's progression. The study also noted that the balance of these cells differs between men and women in healthy people, but this difference disappears in asthma, hinting that the disease overrides normal biological variations.

By tracing the path of these cells from their origin as repair-ready stem cells to their final, often dysfunctional, states, this research provides a clear picture of how asthma hijacks the lung's natural healing process. It shows that the disease is not merely an overreaction to allergens but a fundamental alteration in how the airway tissue rebuilds itself. The discovery of this non-canonical pathway, where cells take a detour through hillock-like states to become mucus factories, offers a new target for understanding the disease. It suggests that therapies aimed at calming this specific repair response or blocking the signals that push cells down this mucus-producing path could potentially break the cycle of chronic inflammation and remodeling that defines asthma. The work moves the field beyond simply observing that the airways are inflamed, providing a detailed map of the cellular machinery that keeps the fire burning.